Clinical Trials

Ascendis Trials Shake Up the Market for Achondroplasia Treatments
Research & Development Ascendis Trials Shake Up the Market for Achondroplasia Treatments

The competitive landscape of pharmaceutical treatments for achondroplasia, a common cause of dwarfism, is experiencing a seismic shift, thanks to the recent clinical trial results from Ascendis Pharma. BioMarin Pharmaceutical, a long-time player in this niche market, finds itself under significant

Can MinervaX and Wacker Biotech Transform GBS Prevention?
Research & Development Can MinervaX and Wacker Biotech Transform GBS Prevention?

In a significant move for maternal and neonatal healthcare, Danish biotech company MinervaX has teamed up with German CDMO Wacker Biotech to develop a groundbreaking prophylactic vaccine for Group B Streptococcus (GBS) infections. This partnership marks a pivotal step in addressing a critical unmet

Can Walgreens Revolutionize Clinical Trials with Its Retail Network?
Research & Development Can Walgreens Revolutionize Clinical Trials with Its Retail Network?

Walgreens, one of the nation’s largest retail pharmacy chains, is embarking on a monumental journey to transform its clinical trials business. This bold move, initiated in June 2022, leverages Walgreens' nationwide retail presence and extensive patient data to tap into the burgeoning p

iTeos’ Belrestotug and Jemperli Combo Shows Promise in Lung Cancer Trial
Research & Development iTeos’ Belrestotug and Jemperli Combo Shows Promise in Lung Cancer Trial

The world of cancer treatment is ever-evolving, and recent developments have brought a glimmer of hope for those battling non-small cell lung cancer (NSCLC). iTeos Therapeutics has unveiled promising results from a mid-stage clinical trial examining the efficacy of combining their drug,

DEA Delays Stall MMJ's Cannabis Trials for MS and Huntington's Disease
Research & Development DEA Delays Stall MMJ's Cannabis Trials for MS and Huntington's Disease

The ongoing legal battle between MMJ BioPharma Cultivation and the Drug Enforcement Administration (DEA) exemplifies the hurdles faced by companies attempting to break into pharmaceutical-grade cannabis research. MMJ BioPharma has encountered significant bureaucratic delays, stalling their efforts

Are New Cancer Treatments Bringing Hope to Patients with NSCLC?
Research & Development Are New Cancer Treatments Bringing Hope to Patients with NSCLC?

Recent advancements in cancer treatments have provided new hope for patients, with significant progress showcased in the biopharmaceutical industry. The interim results of ArriVent BioPharma, Inc.'s Phase 1b FURTHER trial for their drug firmonertinib have been particularly promising. This

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later